Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00027912
DRKS00027912
Recruiting
Not Applicable

Dose-optimized stereotactic body radiotherapy for locally advanced or recurrent pancreatic andenocarcinoma - ORP 001

ordstrahl0 sites30 target enrollmentSeptember 9, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC25Malignant neoplasm of pancreas

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C25
Sponsor
ordstrahl
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ordstrahl

Eligibility Criteria

Inclusion Criteria

  • •Locally advanced pancreatic cancer
  • •\- recurrent pancreatic cancer

Exclusion Criteria

  • •\-previous Radiotherapy
  • •\-more advanced stadium than oligometastatic disease
  • •\-PTV more than 75 ml

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Stereotactic Body Radiotherapy for the Management of Prostate Cancer Local RecurrencesC61Malignant neoplasm of prostate
DRKS00030837Europäisches Radiochirurgie Centrum München50
Active, not recruiting
Phase 1
Addition of stereotactic body radiotherapy (SBRT) to chemotherapy in locally advanced biliary tract cancersocally advanced biliary tract cancerMedDRA version: 21.0Level: LLTClassification code 10004586Term: Bile duct adenocarcinoma non-resectableSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10008594Term: Cholangiocarcinoma non-resectableSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2014-003656-31-GBniversity College London81
Active, not recruiting
Not Applicable
A trial looking at whether stereotactic radiotherapy together with chemotherapy is a useful treatment for people with locally advanced bile duct cancer (ABC-07)Biliary tract cancerCancerMalignant neoplasm of other and unspecified parts of biliary tract
ISRCTN10639376niversity College London83
Recruiting
Phase 2
Cyberknife auto-planning high-dose intensity SBRT trialnon-small cell lung cancer
JPRN-jRCTs032230014Onishi Hiroshi80
Active, not recruiting
Phase 1
Stereotactic body radiotherapy with immunotherapy in early stage non-small cell lung cancer: tolerability and lung effectson small-cell lung cancer (NSCLC) Stage: T1-3( =5cm)N0M0)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-005187-34-GBThe Royal Marsden NHS Foundation Trust31